Compile Data Set for Download or QSAR

Found 276 hits with Last Name = 'frennesson' and Initial = 'db'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Insulin-like growth factor 1 receptor (Rattus norvegicus)	BDBM50318112 ((S)-4-(2-(3-chlorophenyl)-2-hydroxyethylamino)-3-(...) Show SMILES COCCN1CCN(CC1)c1cc(C)c2nc([nH]c2c1)-c1c(NC[C@@H](O)c2cccc(Cl)c2)cc[nH]c1=O |r| Show InChI InChI=1S/C28H33ClN6O3/c1-18-14-21(35-10-8-34(9-11-35)12-13-38-2)16-23-26(18)33-27(32-23)25-22(6-7-30-28(25)37)31-17-24(36)19-4-3-5-20(29)15-19/h3-7,14-16,24,36H,8-13,17H2,1-2H3,(H,32,33)(H2,30,31,37)/t24-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	28	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company Curated by ChEMBL					Assay Description Inhibition of rat IGF1R				Bioorg Med Chem Lett 20: 3182-5 (2010) Article DOI: 10.1016/j.bmcl.2010.03.057 BindingDB Entry DOI: 10.7270/Q2GX4BQB
					More data for this Ligand-Target Pair
Insulin-like growth factor 1 receptor (Homo sapiens (Human))	BDBM107013 (US8592579, 211) Show SMILES O[C@H]1C[C@H](N(C1)c1nc(Nc2cc(n[nH]2)C2CC2)c2cccn2n1)C(=O)Nc1cccnc1 |r| Show InChI InChI=1S/C22H23N9O2/c32-15-9-18(21(33)24-14-3-1-7-23-11-14)30(12-15)22-26-20(17-4-2-8-31(17)29-22)25-19-10-16(27-28-19)13-5-6-13/h1-4,7-8,10-11,13,15,18,32H,5-6,9,12H2,(H,24,33)(H2,25,26,27,28,29)/t15-,18-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	7.4	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Kinase assay using IGF1-receptor.				US Patent US8592579 (2013) BindingDB Entry DOI: 10.7270/Q2SQ8Z12
					More data for this Ligand-Target Pair
Insulin-like growth factor 1 receptor (Homo sapiens (Human))	BDBM107016 (US8592579, 219) Show SMILES CO[C@@H]1C[C@H](N(C1)c1nc(Nc2cc(n[nH]2)C2CC2)c2cccn2n1)C(=O)Nc1ccc(F)nc1 |r| Show InChI InChI=1S/C23H24FN9O2/c1-35-15-9-18(22(34)26-14-6-7-19(24)25-11-14)32(12-15)23-28-21(17-3-2-8-33(17)31-23)27-20-10-16(29-30-20)13-4-5-13/h2-3,6-8,10-11,13,15,18H,4-5,9,12H2,1H3,(H,26,34)(H2,27,28,29,30,31)/t15-,18+/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	7.4	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Kinase assay using IGF1-receptor.				US Patent US8592579 (2013) BindingDB Entry DOI: 10.7270/Q2SQ8Z12
					More data for this Ligand-Target Pair
Insulin-like growth factor 1 receptor (Homo sapiens (Human))	BDBM107018 (US8592579, 254) Show SMILES CO[C@H]1C[C@H](N(C1)c1nc(Nc2cc(n[nH]2)C2CC2)c2cccn2n1)C(=O)Nc1ccc(F)nc1 |r| Show InChI InChI=1S/C23H24FN9O2/c1-35-15-9-18(22(34)26-14-6-7-19(24)25-11-14)32(12-15)23-28-21(17-3-2-8-33(17)31-23)27-20-10-16(29-30-20)13-4-5-13/h2-3,6-8,10-11,13,15,18H,4-5,9,12H2,1H3,(H,26,34)(H2,27,28,29,30,31)/t15-,18-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	7.4	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Kinase assay using IGF1-receptor.				US Patent US8592579 (2013) BindingDB Entry DOI: 10.7270/Q2SQ8Z12
					More data for this Ligand-Target Pair
Insulin-like growth factor 1 receptor (Homo sapiens (Human))	BDBM107023 (US8592579, 288) Show SMILES CC1(CC1)c1cc(Nc2nc(nn3cccc23)N2C[C@@H](O)C[C@H]2C(=O)Nc2ncns2)[nH]n1 |r| Show InChI InChI=1S/C20H22N10O2S/c1-20(4-5-20)14-8-15(27-26-14)23-16-12-3-2-6-30(12)28-18(24-16)29-9-11(31)7-13(29)17(32)25-19-21-10-22-33-19/h2-3,6,8,10-11,13,31H,4-5,7,9H2,1H3,(H,21,22,25,32)(H2,23,24,26,27,28)/t11-,13-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	7.4	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Kinase assay using IGF1-receptor.				US Patent US8592579 (2013) BindingDB Entry DOI: 10.7270/Q2SQ8Z12
					More data for this Ligand-Target Pair
Insulin-like growth factor 1 receptor (Homo sapiens (Human))	BDBM107000 (US8592579, 104) Show SMILES C[C@]1(CCCN1c1nc(Nc2cc(n[nH]2)C2CC2)c2cccn2n1)C(=O)Nc1ccc(F)nc1 |r| Show InChI InChI=1S/C23H24FN9O/c1-23(21(34)26-15-7-8-18(24)25-13-15)9-3-10-32(23)22-28-20(17-4-2-11-33(17)31-22)27-19-12-16(29-30-19)14-5-6-14/h2,4,7-8,11-14H,3,5-6,9-10H2,1H3,(H,26,34)(H2,27,28,29,30,31)/t23-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	Purchase PC cid PC sid PDB UniChem Similars	PDB US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	7.4	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Kinase assay using IGF1-receptor.				US Patent US8592579 (2013) BindingDB Entry DOI: 10.7270/Q2SQ8Z12
					More data for this Ligand-Target Pair				3D Structure (crystal)
Insulin-like growth factor 1 receptor (Homo sapiens (Human))	BDBM107003 (CHEMBL575447 | US8592579, 110) Show SMILES C[C@]1(CCCN1c1nc(Nc2cc([nH]n2)C2CC2)c2cccn2n1)C(=O)Nc1cnccn1 |r| Show InChI InChI=1S/C22H24N10O/c1-22(20(33)26-18-13-23-8-9-24-18)7-3-10-31(22)21-27-19(16-4-2-11-32(16)30-21)25-17-12-15(28-29-17)14-5-6-14/h2,4,8-9,11-14H,3,5-7,10H2,1H3,(H,24,26,33)(H2,25,27,28,29,30)/t22-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	7.4	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Kinase assay using IGF1-receptor.				US Patent US8592579 (2013) BindingDB Entry DOI: 10.7270/Q2SQ8Z12
					More data for this Ligand-Target Pair
Insulin-like growth factor 1 receptor (Homo sapiens (Human))	BDBM107012 (US8592579, 209) Show SMILES O[C@H]1C[C@H](N(C1)c1nc(Nc2cc(n[nH]2)C2CC2)c2cccn2n1)C(=O)Nc1cnccn1 |r| Show InChI InChI=1S/C21H22N10O2/c32-13-8-16(20(33)25-18-10-22-5-6-23-18)30(11-13)21-26-19(15-2-1-7-31(15)29-21)24-17-9-14(27-28-17)12-3-4-12/h1-2,5-7,9-10,12-13,16,32H,3-4,8,11H2,(H,23,25,33)(H2,24,26,27,28,29)/t13-,16-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	7.4	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Kinase assay using IGF1-receptor.				US Patent US8592579 (2013) BindingDB Entry DOI: 10.7270/Q2SQ8Z12
					More data for this Ligand-Target Pair
Insulin-like growth factor 1 receptor (Homo sapiens (Human))	BDBM107020 (US8592579, 256) Show SMILES CO[C@H]1C[C@H](N(C1)c1nc(Nc2cc(n[nH]2)C2CC2)c2cccn2n1)C(=O)Nc1ncns1 |r| Show InChI InChI=1S/C20H22N10O2S/c1-32-12-7-15(18(31)25-20-21-10-22-33-20)29(9-12)19-24-17(14-3-2-6-30(14)28-19)23-16-8-13(26-27-16)11-4-5-11/h2-3,6,8,10-12,15H,4-5,7,9H2,1H3,(H,21,22,25,31)(H2,23,24,26,27,28)/t12-,15-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	7.4	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Kinase assay using IGF1-receptor.				US Patent US8592579 (2013) BindingDB Entry DOI: 10.7270/Q2SQ8Z12
					More data for this Ligand-Target Pair
Insulin-like growth factor 1 receptor (Homo sapiens (Human))	BDBM107021 (US8592579, 259) Show SMILES CC1(CC1)c1cc(Nc2nc(nn3cccc23)N2C[C@@H](O)C[C@H]2C(=O)Nc2cnccn2)[nH]n1 |r| Show InChI InChI=1S/C22H24N10O2/c1-22(4-5-22)16-10-17(29-28-16)25-19-14-3-2-8-32(14)30-21(27-19)31-12-13(33)9-15(31)20(34)26-18-11-23-6-7-24-18/h2-3,6-8,10-11,13,15,33H,4-5,9,12H2,1H3,(H,24,26,34)(H2,25,27,28,29,30)/t13-,15-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	7.4	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Kinase assay using IGF1-receptor.				US Patent US8592579 (2013) BindingDB Entry DOI: 10.7270/Q2SQ8Z12
					More data for this Ligand-Target Pair
Insulin-like growth factor 1 receptor (Homo sapiens (Human))	BDBM107024 (US8592579, 293) Show SMILES F[C@@H]1C[C@H](N(C1)c1nc(Nc2cc(n[nH]2)C2CC2)c2cccn2n1)C(=O)Nc1ncns1 |r| Show InChI InChI=1S/C19H19FN10OS/c20-11-6-14(17(31)25-19-21-9-22-32-19)29(8-11)18-24-16(13-2-1-5-30(13)28-18)23-15-7-12(26-27-15)10-3-4-10/h1-2,5,7,9-11,14H,3-4,6,8H2,(H,21,22,25,31)(H2,23,24,26,27,28)/t11-,14+/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	7.4	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Kinase assay using IGF1-receptor.				US Patent US8592579 (2013) BindingDB Entry DOI: 10.7270/Q2SQ8Z12
					More data for this Ligand-Target Pair
Insulin-like growth factor 1 receptor (Homo sapiens (Human))	BDBM107026 (US8592579, 301) Show SMILES Cc1nnn(n1)[C@H]1C[C@H](N(C1)c1nc(Nc2cc(n[nH]2)C2CC2)c2cccn2n1)C(=O)Nc1ccc(F)nc1 |r| Show InChI InChI=1S/C24H24FN13O/c1-13-30-35-38(33-13)16-9-19(23(39)27-15-6-7-20(25)26-11-15)36(12-16)24-29-22(18-3-2-8-37(18)34-24)28-21-10-17(31-32-21)14-4-5-14/h2-3,6-8,10-11,14,16,19H,4-5,9,12H2,1H3,(H,27,39)(H2,28,29,31,32,34)/t16-,19-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	7.4	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Kinase assay using IGF1-receptor.				US Patent US8592579 (2013) BindingDB Entry DOI: 10.7270/Q2SQ8Z12
					More data for this Ligand-Target Pair
Insulin-like growth factor 1 receptor (Homo sapiens (Human))	BDBM107022 (US8592579, 287) Show SMILES O[C@H]1C[C@H](N(C1)c1nc(Nc2cc(n[nH]2)C2CC2)c2cccn2n1)C(=O)Nc1ncns1 |r| Show InChI InChI=1S/C19H20N10O2S/c30-11-6-14(17(31)24-19-20-9-21-32-19)28(8-11)18-23-16(13-2-1-5-29(13)27-18)22-15-7-12(25-26-15)10-3-4-10/h1-2,5,7,9-11,14,30H,3-4,6,8H2,(H,20,21,24,31)(H2,22,23,25,26,27)/t11-,14-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	7.4	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Kinase assay using IGF1-receptor.				US Patent US8592579 (2013) BindingDB Entry DOI: 10.7270/Q2SQ8Z12
					More data for this Ligand-Target Pair
Insulin-like growth factor 1 receptor (Homo sapiens (Human))	BDBM107028 (US8592579, 318) Show SMILES F[C@H]1C[C@H](N(C1)c1nc(Nc2cc(n[nH]2)C2CC2)c2cccn2n1)C(=O)Nc1ncns1 |r| Show InChI InChI=1S/C19H19FN10OS/c20-11-6-14(17(31)25-19-21-9-22-32-19)29(8-11)18-24-16(13-2-1-5-30(13)28-18)23-15-7-12(26-27-15)10-3-4-10/h1-2,5,7,9-11,14H,3-4,6,8H2,(H,21,22,25,31)(H2,23,24,26,27,28)/t11-,14-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	7.4	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Kinase assay using IGF1-receptor.				US Patent US8592579 (2013) BindingDB Entry DOI: 10.7270/Q2SQ8Z12
					More data for this Ligand-Target Pair
Insulin-like growth factor 1 receptor (Homo sapiens (Human))	BDBM107001 (US8592579, 105) Show SMILES C[C@]1(CCCN1c1nc(Nc2cc(n[nH]2)C2CC2)c2cccn2n1)C(=O)Nc1nccs1 |r| Show InChI InChI=1S/C21H23N9OS/c1-21(18(31)25-20-22-8-11-32-20)7-3-9-29(21)19-24-17(15-4-2-10-30(15)28-19)23-16-12-14(26-27-16)13-5-6-13/h2,4,8,10-13H,3,5-7,9H2,1H3,(H,22,25,31)(H2,23,24,26,27,28)/t21-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	4	n/a	n/a	n/a	n/a	7.4	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Kinase assay using IGF1-receptor.				US Patent US8592579 (2013) BindingDB Entry DOI: 10.7270/Q2SQ8Z12
					More data for this Ligand-Target Pair
Programmed cell death protein 1 (Homo sapiens)	BDBM436120 (US10590105, Example 1012) Show SMILES Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN[C@](C)(CO)C(O)=O)cc2Cl)cccc1-c1ccc2ocnc2c1 |r| Show InChI InChI=1S/C33H29ClN4O6/c1-20-24(4-3-5-26(20)23-6-7-29-28(10-23)37-19-44-29)17-43-31-11-30(42-16-22-8-21(12-35)13-36-14-22)25(9-27(31)34)15-38-33(2,18-39)32(40)41/h3-11,13-14,19,38-39H,15-18H2,1-2H3,(H,40,41)/t33-/m1/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Meyers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10590105 (2020) BindingDB Entry DOI: 10.7270/Q2ST7SVD
					More data for this Ligand-Target Pair
Programmed cell death protein 1 (Homo sapiens)	BDBM436124 (US10590105, Example 1016) Show SMILES Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CNC(C)(C)C(O)=O)cc2Cl)cccc1-c1ccc2ncoc2c1 Show InChI InChI=1S/C33H29ClN4O5/c1-20-24(5-4-6-26(20)23-7-8-28-31(11-23)43-19-37-28)18-42-30-12-29(41-17-22-9-21(13-35)14-36-15-22)25(10-27(30)34)16-38-33(2,3)32(39)40/h4-12,14-15,19,38H,16-18H2,1-3H3,(H,39,40)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Meyers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10590105 (2020) BindingDB Entry DOI: 10.7270/Q2ST7SVD
					More data for this Ligand-Target Pair
Programmed cell death protein 1 (Homo sapiens)	BDBM436128 (US10590105, Example 1019) Show SMILES Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN[C@](C)(CO)C(O)=O)cc2Cl)cccc1-c1ccc2ccoc2c1 |r| Show InChI InChI=1S/C34H30ClN3O6/c1-21-26(4-3-5-28(21)25-7-6-24-8-9-42-30(24)12-25)19-44-32-13-31(43-18-23-10-22(14-36)15-37-16-23)27(11-29(32)35)17-38-34(2,20-39)33(40)41/h3-13,15-16,38-39H,17-20H2,1-2H3,(H,40,41)/t34-/m1/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Meyers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10590105 (2020) BindingDB Entry DOI: 10.7270/Q2ST7SVD
					More data for this Ligand-Target Pair
Programmed cell death protein 1 (Homo sapiens)	BDBM436130 (US10590105, Example 1020) Show SMILES C[C@H]1CCCN1Cc1cc(Cl)c(OCc2cccc(c2C)-c2ccc3ccoc3c2)cc1OCc1cncc(c1)C#N |r| Show InChI InChI=1S/C35H32ClN3O3/c1-23-5-4-11-39(23)20-30-14-32(36)35(16-34(30)41-21-26-13-25(17-37)18-38-19-26)42-22-29-6-3-7-31(24(29)2)28-9-8-27-10-12-40-33(27)15-28/h3,6-10,12-16,18-19,23H,4-5,11,20-22H2,1-2H3/t23-/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Meyers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10590105 (2020) BindingDB Entry DOI: 10.7270/Q2ST7SVD
					More data for this Ligand-Target Pair
Programmed cell death protein 1 (Homo sapiens)	BDBM436133 (US10590105, Example 1021) Show SMILES Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN[C@](C)(CO)C(O)=O)cc2Cl)cccc1-c1ccc2scnc2c1 |r| Show InChI InChI=1S/C33H29ClN4O5S/c1-20-24(4-3-5-26(20)23-6-7-31-28(10-23)37-19-44-31)17-43-30-11-29(42-16-22-8-21(12-35)13-36-14-22)25(9-27(30)34)15-38-33(2,18-39)32(40)41/h3-11,13-14,19,38-39H,15-18H2,1-2H3,(H,40,41)/t33-/m1/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Meyers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10590105 (2020) BindingDB Entry DOI: 10.7270/Q2ST7SVD
					More data for this Ligand-Target Pair
Programmed cell death protein 1 (Homo sapiens)	BDBM436141 (US10590105, Example 1028) Show SMILES Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN[C@](C)(CO)C(O)=O)cc2Cl)cccc1-c1ccc2oc(CCN3CC[C@@H](O)C3)nc2c1 |r| Show InChI InChI=1S/C39H40ClN5O7/c1-24-28(4-3-5-31(24)27-6-7-34-33(14-27)44-37(52-34)9-11-45-10-8-30(47)20-45)22-51-36-15-35(50-21-26-12-25(16-41)17-42-18-26)29(13-32(36)40)19-43-39(2,23-46)38(48)49/h3-7,12-15,17-18,30,43,46-47H,8-11,19-23H2,1-2H3,(H,48,49)/t30-,39-/m1/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Meyers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10590105 (2020) BindingDB Entry DOI: 10.7270/Q2ST7SVD
					More data for this Ligand-Target Pair
Programmed cell death protein 1 (Homo sapiens)	BDBM436142 (US10590105, Example 1029) Show SMILES Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN3CCCC[C@H]3C(O)=O)cc2Cl)cccc1-c1ccc2oc(CCN3CC[C@@H](O)C3)nc2c1 |r| Show InChI InChI=1S/C41H42ClN5O6/c1-26-30(5-4-6-33(26)29-8-9-37-35(17-29)45-40(53-37)11-14-46-13-10-32(48)23-46)25-52-39-18-38(51-24-28-15-27(19-43)20-44-21-28)31(16-34(39)42)22-47-12-3-2-7-36(47)41(49)50/h4-6,8-9,15-18,20-21,32,36,48H,2-3,7,10-14,22-25H2,1H3,(H,49,50)/t32-,36+/m1/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Meyers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10590105 (2020) BindingDB Entry DOI: 10.7270/Q2ST7SVD
					More data for this Ligand-Target Pair
Programmed cell death protein 1 (Homo sapiens)	BDBM436148 (US10590105, Example 1034) Show SMILES Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN[C@H](CO)C(O)=O)cc2Cl)cccc1-c1ccc2nccnc2c1 |r| Show InChI InChI=1S/C33H28ClN5O5/c1-20-24(3-2-4-26(20)23-5-6-28-29(11-23)38-8-7-37-28)19-44-32-12-31(43-18-22-9-21(13-35)14-36-15-22)25(10-27(32)34)16-39-30(17-40)33(41)42/h2-12,14-15,30,39-40H,16-19H2,1H3,(H,41,42)/t30-/m1/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Meyers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10590105 (2020) BindingDB Entry DOI: 10.7270/Q2ST7SVD
					More data for this Ligand-Target Pair
Programmed cell death protein 1 (Homo sapiens)	BDBM436149 (US10590105, Example 1035) Show SMILES Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN[C@](C)(CO)C(O)=O)cc2Cl)cccc1-c1ccc2nccnc2c1 |r| Show InChI InChI=1S/C34H30ClN5O5/c1-21-25(4-3-5-27(21)24-6-7-29-30(12-24)39-9-8-38-29)19-45-32-13-31(44-18-23-10-22(14-36)15-37-16-23)26(11-28(32)35)17-40-34(2,20-41)33(42)43/h3-13,15-16,40-41H,17-20H2,1-2H3,(H,42,43)/t34-/m1/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Meyers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10590105 (2020) BindingDB Entry DOI: 10.7270/Q2ST7SVD
					More data for this Ligand-Target Pair
Programmed cell death protein 1 (Homo sapiens)	BDBM436150 (US10590105, Example 1036) Show SMILES Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN[C@@](C)(CO)C(O)=O)cc2Cl)cccc1-c1ccc2nccnc2c1 |r| Show InChI InChI=1S/C34H30ClN5O5/c1-21-25(4-3-5-27(21)24-6-7-29-30(12-24)39-9-8-38-29)19-45-32-13-31(44-18-23-10-22(14-36)15-37-16-23)26(11-28(32)35)17-40-34(2,20-41)33(42)43/h3-13,15-16,40-41H,17-20H2,1-2H3,(H,42,43)/t34-/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Meyers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10590105 (2020) BindingDB Entry DOI: 10.7270/Q2ST7SVD
					More data for this Ligand-Target Pair
Programmed cell death protein 1 (Homo sapiens)	BDBM436157 (US10590105, Example 1041) Show SMILES Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN3CCCC[C@H]3C(O)=O)cc2Cl)cccc1-c1ccc2ocnc2c1 |r| Show InChI InChI=1S/C35H31ClN4O5/c1-22-26(5-4-6-28(22)25-8-9-32-30(13-25)39-21-45-32)20-44-34-14-33(43-19-24-11-23(15-37)16-38-17-24)27(12-29(34)36)18-40-10-3-2-7-31(40)35(41)42/h4-6,8-9,11-14,16-17,21,31H,2-3,7,10,18-20H2,1H3,(H,41,42)/t31-/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Meyers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10590105 (2020) BindingDB Entry DOI: 10.7270/Q2ST7SVD
					More data for this Ligand-Target Pair
Programmed cell death protein 1 (Homo sapiens)	BDBM436158 (US10590105, Example 2001) Show SMILES Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CNC(C)(CO)CO)cc2Cl)cccc1-c1ccnc(OCCCN2CCCCC2)c1Cl Show InChI InChI=1S/C39H45Cl2N5O5/c1-27-30(8-6-9-32(27)33-10-11-44-38(37(33)41)49-15-7-14-46-12-4-3-5-13-46)24-51-36-18-35(50-23-29-16-28(19-42)20-43-21-29)31(17-34(36)40)22-45-39(2,25-47)26-48/h6,8-11,16-18,20-21,45,47-48H,3-5,7,12-15,22-26H2,1-2H3	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Meyers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10590105 (2020) BindingDB Entry DOI: 10.7270/Q2ST7SVD
					More data for this Ligand-Target Pair
Programmed cell death protein 1 (Homo sapiens)	BDBM436159 (US10590105, Example 2002) Show SMILES Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CNC(C)(CO)CO)cc2Cl)cccc1-c1nccc(OCCCN2CC[C@@H](O)C2)c1Cl |r| Show InChI InChI=1S/C38H43Cl2N5O6/c1-25-28(5-3-6-31(25)37-36(40)33(7-9-43-37)49-12-4-10-45-11-8-30(48)20-45)22-51-35-15-34(50-21-27-13-26(16-41)17-42-18-27)29(14-32(35)39)19-44-38(2,23-46)24-47/h3,5-7,9,13-15,17-18,30,44,46-48H,4,8,10-12,19-24H2,1-2H3/t30-/m1/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Meyers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10590105 (2020) BindingDB Entry DOI: 10.7270/Q2ST7SVD
					More data for this Ligand-Target Pair
Programmed cell death protein 1 (Homo sapiens)	BDBM436161 (US10590105, Example 2004) Show SMILES Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CNC(C)(CO)CO)cc2Cl)cccc1-c1nccc(OCCCO)c1Cl Show InChI InChI=1S/C34H36Cl2N4O6/c1-22-25(5-3-6-27(22)33-32(36)29(7-8-39-33)44-10-4-9-41)19-46-31-13-30(45-18-24-11-23(14-37)15-38-16-24)26(12-28(31)35)17-40-34(2,20-42)21-43/h3,5-8,11-13,15-16,40-43H,4,9-10,17-21H2,1-2H3	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Meyers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10590105 (2020) BindingDB Entry DOI: 10.7270/Q2ST7SVD
					More data for this Ligand-Target Pair
Programmed cell death protein 1 (Homo sapiens)	BDBM436163 (US10590105, Example 2005) Show SMILES Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN3CCCC[C@H]3C(O)=O)cc2Cl)cncc1-c1cccc(OCCCN2CC[C@@H](O)C2)c1C |r| Show InChI InChI=1S/C41H46ClN5O6/c1-27-32(21-45-22-35(27)34-7-5-9-38(28(34)2)51-14-6-11-46-13-10-33(48)24-46)26-53-40-17-39(52-25-30-15-29(18-43)19-44-20-30)31(16-36(40)42)23-47-12-4-3-8-37(47)41(49)50/h5,7,9,15-17,19-22,33,37,48H,3-4,6,8,10-14,23-26H2,1-2H3,(H,49,50)/t33-,37+/m1/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Meyers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10590105 (2020) BindingDB Entry DOI: 10.7270/Q2ST7SVD
					More data for this Ligand-Target Pair
Programmed cell death protein 1 (Homo sapiens)	BDBM436166 (US10590105, Example 2008) Show SMILES Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CNC(C)(CO)CO)cc2Cl)cncc1-c1cccc(OCCCN2CC[C@@H](O)C2)c1C |r| Show InChI InChI=1S/C39H46ClN5O6/c1-26-31(18-43-20-34(26)33-6-4-7-36(27(33)2)49-11-5-9-45-10-8-32(48)21-45)23-51-38-14-37(50-22-29-12-28(15-41)16-42-17-29)30(13-35(38)40)19-44-39(3,24-46)25-47/h4,6-7,12-14,16-18,20,32,44,46-48H,5,8-11,19,21-25H2,1-3H3/t32-/m1/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Meyers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10590105 (2020) BindingDB Entry DOI: 10.7270/Q2ST7SVD
					More data for this Ligand-Target Pair
Programmed cell death protein 1 (Homo sapiens)	BDBM436169 (US10590105, Example 2012) Show SMILES Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN[C@@](C)(CO)C(O)=O)cc2Cl)nccc1-c1cccc(OCCCN2CC[C@@H](O)C2)c1C |r| Show InChI InChI=1S/C39H44ClN5O7/c1-25-32(31-6-4-7-35(26(31)2)50-13-5-11-45-12-9-30(47)21-45)8-10-43-34(25)23-52-37-16-36(51-22-28-14-27(17-41)18-42-19-28)29(15-33(37)40)20-44-39(3,24-46)38(48)49/h4,6-8,10,14-16,18-19,30,44,46-47H,5,9,11-13,20-24H2,1-3H3,(H,48,49)/t30-,39+/m1/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Meyers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10590105 (2020) BindingDB Entry DOI: 10.7270/Q2ST7SVD
					More data for this Ligand-Target Pair
Programmed cell death protein 1 (Homo sapiens)	BDBM436170 (US10590105, Example 2013) Show SMILES CCC(CO)(CO)NCc1cc(Cl)c(OCc2nccc(c2C)-c2cccc(OCCCN3CC[C@@H](O)C3)c2C)cc1OCc1cncc(c1)C#N |r| Show InChI InChI=1S/C40H48ClN5O6/c1-4-40(25-47,26-48)45-21-31-16-35(41)39(17-38(31)51-23-30-15-29(18-42)19-43-20-30)52-24-36-27(2)34(9-11-44-36)33-7-5-8-37(28(33)3)50-14-6-12-46-13-10-32(49)22-46/h5,7-9,11,15-17,19-20,32,45,47-49H,4,6,10,12-14,21-26H2,1-3H3/t32-/m1/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Meyers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10590105 (2020) BindingDB Entry DOI: 10.7270/Q2ST7SVD
					More data for this Ligand-Target Pair
Programmed cell death protein 1 (Homo sapiens)	BDBM436172 (US10590105, Example 2015) Show SMILES Cc1c(COc2cc(OCc3cncc(c3)C#N)c(CN[C@@](C)(CO)C(O)=O)cc2Cl)nccc1-c1cccc(OCCCN2CCCCC2)c1C |r| Show InChI InChI=1S/C40H46ClN5O6/c1-27-33(32-9-7-10-36(28(32)2)50-16-8-15-46-13-5-4-6-14-46)11-12-44-35(27)25-52-38-19-37(51-24-30-17-29(20-42)21-43-22-30)31(18-34(38)41)23-45-40(3,26-47)39(48)49/h7,9-12,17-19,21-22,45,47H,4-6,8,13-16,23-26H2,1-3H3,(H,48,49)/t40-/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Meyers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10590105 (2020) BindingDB Entry DOI: 10.7270/Q2ST7SVD
					More data for this Ligand-Target Pair
Programmed cell death protein 1 (Homo sapiens)	BDBM436173 (US10590105, Example 2016) Show SMILES CCC(CO)(CO)NCc1cc(Cl)c(OCc2nccc(c2C)-c2cccc(OCCCN3CCCCC3)c2C)cc1OCc1cncc(c1)C#N Show InChI InChI=1S/C41H50ClN5O5/c1-4-41(27-48,28-49)46-24-33-19-36(42)40(20-39(33)51-25-32-18-31(21-43)22-44-23-32)52-26-37-29(2)35(12-13-45-37)34-10-8-11-38(30(34)3)50-17-9-16-47-14-6-5-7-15-47/h8,10-13,18-20,22-23,46,48-49H,4-7,9,14-17,24-28H2,1-3H3	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Meyers Squibb Company US Patent					Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...				US Patent US10590105 (2020) BindingDB Entry DOI: 10.7270/Q2ST7SVD
					More data for this Ligand-Target Pair
Insulin-like growth factor 1 receptor (Homo sapiens (Human))	BDBM107015 (US8592579, 216) Show SMILES O[C@@H]1C[C@H](N(C1)c1nc(Nc2cc(n[nH]2)C2CC2)c2cccn2n1)C(=O)Nc1nccs1 |r| Show InChI InChI=1S/C20H21N9O2S/c30-12-8-15(18(31)24-20-21-5-7-32-20)28(10-12)19-23-17(14-2-1-6-29(14)27-19)22-16-9-13(25-26-16)11-3-4-11/h1-2,5-7,9,11-12,15,30H,3-4,8,10H2,(H,21,24,31)(H2,22,23,25,26,27)/t12-,15+/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	7.4	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Kinase assay using IGF1-receptor.				US Patent US8592579 (2013) BindingDB Entry DOI: 10.7270/Q2SQ8Z12
					More data for this Ligand-Target Pair
Insulin-like growth factor 1 receptor (Homo sapiens (Human))	BDBM107017 (US8592579, 243) Show SMILES CC(C)N1CCCC(C1)NC(=O)C1C[C@H](O)CN1c1nc(Nc2cn(cn2)C(C)C)c2cccn2n1 |r| Show InChI InChI=1S/C25H37N9O2/c1-16(2)31-9-5-7-18(12-31)27-24(36)21-11-19(35)13-33(21)25-29-23(20-8-6-10-34(20)30-25)28-22-14-32(15-26-22)17(3)4/h6,8,10,14-19,21,35H,5,7,9,11-13H2,1-4H3,(H,27,36)(H,28,29,30)/t18?,19-,21?/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	7.4	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Kinase assay using IGF1-receptor.				US Patent US8592579 (2013) BindingDB Entry DOI: 10.7270/Q2SQ8Z12
					More data for this Ligand-Target Pair
Insulin-like growth factor 1 receptor (Homo sapiens (Human))	BDBM107025 (US8592579, 294) Show SMILES CC1(CC1)c1cc(Nc2nc(nn3cccc23)N2C[C@H](F)C[C@H]2C(=O)Nc2ncns2)[nH]n1 |r| Show InChI InChI=1S/C20H21FN10OS/c1-20(4-5-20)14-8-15(28-27-14)24-16-12-3-2-6-31(12)29-18(25-16)30-9-11(21)7-13(30)17(32)26-19-22-10-23-33-19/h2-3,6,8,10-11,13H,4-5,7,9H2,1H3,(H,22,23,26,32)(H2,24,25,27,28,29)/t11-,13+/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	7.4	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Kinase assay using IGF1-receptor.				US Patent US8592579 (2013) BindingDB Entry DOI: 10.7270/Q2SQ8Z12
					More data for this Ligand-Target Pair
Insulin-like growth factor 1 receptor (Homo sapiens (Human))	BDBM107004 (US8592579, 111) Show SMILES C[C@]1(CCCN1c1nc(Nc2cc([nH]n2)C2CC2)c2cccn2n1)C(=O)Nc1ccncn1 |r| Show InChI InChI=1S/C22H24N10O/c1-22(20(33)26-17-7-9-23-13-24-17)8-3-10-31(22)21-27-19(16-4-2-11-32(16)30-21)25-18-12-15(28-29-18)14-5-6-14/h2,4,7,9,11-14H,3,5-6,8,10H2,1H3,(H,23,24,26,33)(H2,25,27,28,29,30)/t22-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	7	n/a	n/a	n/a	n/a	7.4	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Kinase assay using IGF1-receptor.				US Patent US8592579 (2013) BindingDB Entry DOI: 10.7270/Q2SQ8Z12
					More data for this Ligand-Target Pair
Insulin-like growth factor 1 receptor (Homo sapiens (Human))	BDBM107027 (US8592579, 317) Show SMILES C[C@]1(CCCN1c1nc(Nc2ncc(s2)C(N)=O)c2cccn2n1)C(=O)Nc1ccc(F)nc1 |r| Show InChI InChI=1S/C21H20FN9O2S/c1-21(18(33)26-12-5-6-15(22)24-10-12)7-3-8-30(21)19-27-17(13-4-2-9-31(13)29-19)28-20-25-11-14(34-20)16(23)32/h2,4-6,9-11H,3,7-8H2,1H3,(H2,23,32)(H,26,33)(H,25,27,28,29)/t21-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	14	n/a	n/a	n/a	n/a	7.4	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Kinase assay using IGF1-receptor.				US Patent US8592579 (2013) BindingDB Entry DOI: 10.7270/Q2SQ8Z12
					More data for this Ligand-Target Pair
Insulin-like growth factor 1 receptor (Homo sapiens (Human))	BDBM50318122 ((S)-4-(2-(3-chlorophenyl)-2-hydroxyethylamino)-3-(...) Show SMILES Cc1cc(cc2[nH]c(nc12)-c1c(NC[C@@H](O)c2cccc(Cl)c2)cc[nH]c1=O)N1CCN(CCCO)CC1 |r| Show InChI InChI=1S/C28H33ClN6O3/c1-18-14-21(35-11-9-34(10-12-35)8-3-13-36)16-23-26(18)33-27(32-23)25-22(6-7-30-28(25)38)31-17-24(37)19-4-2-5-20(29)15-19/h2,4-7,14-16,24,36-37H,3,8-13,17H2,1H3,(H,32,33)(H2,30,31,38)/t24-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	16	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company Curated by ChEMBL					Assay Description Inhibition of IGF1R				Bioorg Med Chem Lett 20: 3182-5 (2010) Article DOI: 10.1016/j.bmcl.2010.03.057 BindingDB Entry DOI: 10.7270/Q2GX4BQB
					More data for this Ligand-Target Pair
Insulin-like growth factor 1 receptor (Homo sapiens (Human))	BDBM50318112 ((S)-4-(2-(3-chlorophenyl)-2-hydroxyethylamino)-3-(...) Show SMILES COCCN1CCN(CC1)c1cc(C)c2nc([nH]c2c1)-c1c(NC[C@@H](O)c2cccc(Cl)c2)cc[nH]c1=O |r| Show InChI InChI=1S/C28H33ClN6O3/c1-18-14-21(35-10-8-34(9-11-35)12-13-38-2)16-23-26(18)33-27(32-23)25-22(6-7-30-28(25)37)31-17-24(36)19-4-3-5-20(29)15-19/h3-7,14-16,24,36H,8-13,17H2,1-2H3,(H,32,33)(H2,30,31,37)/t24-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	16	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company Curated by ChEMBL					Assay Description Inhibition of IGF1R				Bioorg Med Chem Lett 20: 3182-5 (2010) Article DOI: 10.1016/j.bmcl.2010.03.057 BindingDB Entry DOI: 10.7270/Q2GX4BQB
					More data for this Ligand-Target Pair
Insulin-like growth factor 1 receptor (Homo sapiens (Human))	BDBM107002 (US8592579, 107) Show SMILES C[C@]1(CCCN1c1nc(Nc2cc(n[nH]2)C2CC2)c2cccn2n1)C(=O)Nc1ncc(Cl)s1 |r| Show InChI InChI=1S/C21H22ClN9OS/c1-21(18(32)26-20-23-11-15(22)33-20)7-3-8-30(21)19-25-17(14-4-2-9-31(14)29-19)24-16-10-13(27-28-16)12-5-6-12/h2,4,9-12H,3,5-8H2,1H3,(H,23,26,32)(H2,24,25,27,28,29)/t21-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	16	n/a	n/a	n/a	n/a	7.4	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Kinase assay using IGF1-receptor.				US Patent US8592579 (2013) BindingDB Entry DOI: 10.7270/Q2SQ8Z12
					More data for this Ligand-Target Pair
Insulin-like growth factor 1 receptor (Homo sapiens (Human))	BDBM50318113 ((S)-4-(2-(3-chlorophenyl)-2-hydroxyethylamino)-3-(...) Show SMILES CCN1CCN(CC1)c1cc(C)c2nc([nH]c2c1)-c1c(NC[C@@H](O)c2cccc(Cl)c2)cc[nH]c1=O |r| Show InChI InChI=1S/C27H31ClN6O2/c1-3-33-9-11-34(12-10-33)20-13-17(2)25-22(15-20)31-26(32-25)24-21(7-8-29-27(24)36)30-16-23(35)18-5-4-6-19(28)14-18/h4-8,13-15,23,35H,3,9-12,16H2,1-2H3,(H,31,32)(H2,29,30,36)/t23-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	17	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company Curated by ChEMBL					Assay Description Inhibition of IGF1R				Bioorg Med Chem Lett 20: 3182-5 (2010) Article DOI: 10.1016/j.bmcl.2010.03.057 BindingDB Entry DOI: 10.7270/Q2GX4BQB
					More data for this Ligand-Target Pair
Insulin-like growth factor 1 receptor (Homo sapiens (Human))	BDBM50313558 ((S)-4-(2-(3-chlorophenyl)-2-hydroxyethylamino)-3-(...) Show SMILES CN1CCN(CC1)c1cc(C)c2nc([nH]c2c1)-c1c(NC[C@@H](O)c2cccc(Cl)c2)cc[nH]c1=O |r| Show InChI InChI=1S/C26H29ClN6O2/c1-16-12-19(33-10-8-32(2)9-11-33)14-21-24(16)31-25(30-21)23-20(6-7-28-26(23)35)29-15-22(34)17-4-3-5-18(27)13-17/h3-7,12-14,22,34H,8-11,15H2,1-2H3,(H,30,31)(H2,28,29,35)/t22-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	18	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company Curated by ChEMBL					Assay Description Inhibition of IGF1R				Bioorg Med Chem Lett 20: 3182-5 (2010) Article DOI: 10.1016/j.bmcl.2010.03.057 BindingDB Entry DOI: 10.7270/Q2GX4BQB
					More data for this Ligand-Target Pair
Insulin-like growth factor 1 receptor (Homo sapiens (Human))	BDBM50313558 ((S)-4-(2-(3-chlorophenyl)-2-hydroxyethylamino)-3-(...) Show SMILES CN1CCN(CC1)c1cc(C)c2nc([nH]c2c1)-c1c(NC[C@@H](O)c2cccc(Cl)c2)cc[nH]c1=O |r| Show InChI InChI=1S/C26H29ClN6O2/c1-16-12-19(33-10-8-32(2)9-11-33)14-21-24(16)31-25(30-21)23-20(6-7-28-26(23)35)29-15-22(34)17-4-3-5-18(27)13-17/h3-7,12-14,22,34H,8-11,15H2,1-2H3,(H,30,31)(H2,28,29,35)/t22-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	18	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Co. Curated by ChEMBL					Assay Description Inhibition of human recombinant IGF-1R tyrosine kinase expressed in baculovirus system assessed as [33gamma]ATP phosphorylation of poly(Glu/Tyr) subs...				Bioorg Med Chem Lett 20: 1744-8 (2010) Article DOI: 10.1016/j.bmcl.2010.01.087 BindingDB Entry DOI: 10.7270/Q2MW2H95
					More data for this Ligand-Target Pair
Insulin-like growth factor 1 receptor (Homo sapiens (Human))	BDBM107009 (US8592579, 154) Show SMILES C[C@]1(CCCN1c1nc(Nc2cc([nH]n2)C2CC2)c2cccn2n1)C(=O)Nc1ncccn1 |r| Show InChI InChI=1S/C22H24N10O/c1-22(19(33)27-20-23-9-4-10-24-20)8-3-11-31(22)21-26-18(16-5-2-12-32(16)30-21)25-17-13-15(28-29-17)14-6-7-14/h2,4-5,9-10,12-14H,3,6-8,11H2,1H3,(H,23,24,27,33)(H2,25,26,28,29,30)/t22-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	21	n/a	n/a	n/a	n/a	7.4	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Kinase assay using IGF1-receptor.				US Patent US8592579 (2013) BindingDB Entry DOI: 10.7270/Q2SQ8Z12
					More data for this Ligand-Target Pair
Steroid 17-alpha-hydroxylase/17,20 lyase (Homo sapiens (Human))	BDBM208952 (US9266880, 7) Show SMILES NS(=O)(=O)c1cccc(c1)-n1ncc2c(ccnc12)-c1cncc2ccccc12 Show InChI InChI=1S/C21H15N5O2S/c22-29(27,28)16-6-3-5-15(10-16)26-21-20(13-25-26)18(8-9-24-21)19-12-23-11-14-4-1-2-7-17(14)19/h1-13H,(H2,22,27,28)	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	23	n/a	n/a	n/a	n/a	7.2	4
Bristol-Myers Squibb Company US Patent					Assay Description The assays were performed in U-bottom 384-well optiplates. The final assay volume was 15 ul prepared from 7.5 ul additions of microsomes (prepared as...				US Patent US9266880 (2016) BindingDB Entry DOI: 10.7270/Q24T6H69
					More data for this Ligand-Target Pair
Insulin-like growth factor 1 receptor (Homo sapiens (Human))	BDBM50318121 ((S)-4-(2-(3-chlorophenyl)-2-hydroxyethylamino)-3-(...) Show SMILES Cc1cc(cc2[nH]c(nc12)-c1c(NC[C@@H](O)c2cccc(Cl)c2)cc[nH]c1=O)N1CCN(CCO)CC1 |r| Show InChI InChI=1S/C27H31ClN6O3/c1-17-13-20(34-9-7-33(8-10-34)11-12-35)15-22-25(17)32-26(31-22)24-21(5-6-29-27(24)37)30-16-23(36)18-3-2-4-19(28)14-18/h2-6,13-15,23,35-36H,7-12,16H2,1H3,(H,31,32)(H2,29,30,37)/t23-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	26	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company Curated by ChEMBL					Assay Description Inhibition of IGF1R				Bioorg Med Chem Lett 20: 3182-5 (2010) Article DOI: 10.1016/j.bmcl.2010.03.057 BindingDB Entry DOI: 10.7270/Q2GX4BQB
					More data for this Ligand-Target Pair
Insulin-like growth factor 1 receptor (Homo sapiens (Human))	BDBM50318120 ((S)-4-(2-(3-chlorophenyl)-2-hydroxyethylamino)-3-(...) Show SMILES Cc1cc(cc2[nH]c(nc12)-c1c(NC[C@@H](O)c2cccc(Cl)c2)cc[nH]c1=O)N1CCN(CC1)S(C)(=O)=O |r| Show InChI InChI=1S/C26H29ClN6O4S/c1-16-12-19(32-8-10-33(11-9-32)38(2,36)37)14-21-24(16)31-25(30-21)23-20(6-7-28-26(23)35)29-15-22(34)17-4-3-5-18(27)13-17/h3-7,12-14,22,34H,8-11,15H2,1-2H3,(H,30,31)(H2,28,29,35)/t22-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	27	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company Curated by ChEMBL					Assay Description Inhibition of IGF1R				Bioorg Med Chem Lett 20: 3182-5 (2010) Article DOI: 10.1016/j.bmcl.2010.03.057 BindingDB Entry DOI: 10.7270/Q2GX4BQB
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 276 total )  |  Next  |  Last  >>

Jump to: